Jiangxi Fushine Pharmaceutical Co., Ltd. Stock: price and insider trades · China
富祥股份
No insider purchase over the last 90 days. The latest, by 刘英, was filed 26 Jun 2024.
Jiangxi Fushine Pharmaceutical Co., Ltd.: what insiders have been doing
This page follows insider dealings at Jiangxi Fushine Pharmaceutical Co., Ltd. as filed with SSE / SZSE (CSRC), a company from the Health Care sector. Nothing new has been filed by managers of Jiangxi Fushine Pharmaceutical Co., Ltd. in twelve months, the latest record being from 26 June 2024.
Looking back to 2021, when coverage begins, insiders filed 13 purchases and 1 sale.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and Vetoquinol SA. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
Since the insiders bought
- -1.5%Entry CN¥8.89 · Close at T+365 CN¥8.76
- -25.5%Entry CN¥11.65 · Close at T+365 CN¥8.68
- +19.0%Entry CN¥7.14 · Close at T+365 CN¥8.50
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 6,000 shares16.4% of flowA股XSHESZSE:173000007791572130Canonical exit: 24 Sept 2024 (T+90)
- 30,000 shares83.6% of flowA股XSHESZSE:173000007783422660Canonical exit: 22 Sept 2024 (T+90)
- 920,000 shares42.4% of flowA股XSHESZSE:173000007612634600Canonical exit: 4 Aug 2024 (T+90)
- 604,700 shares25.0% of flowA股XSHESZSE:173000007607480200Canonical exit: 29 Jul 2024 (T+90)
- 825,400 shares32.6% of flowA股XSHESZSE:173000007586818300Canonical exit: 28 Jul 2024 (T+90)
- 10,000 shares100.0% of flowA股XSHESZSE:173000007330443420Canonical exit: 19 May 2024 (T+90)
- 1,500 shares7.0% of flowA股XSHESZSE:173000005918555200
- 10,000 shares46.4% of flowA股XSHESZSE:173000005470124540Canonical exit: 21 Jul 2022 (T+90)
- 996,600 shares26.5% of flowA股XSHESZSE:173000005252884100Canonical exit: 28 Apr 2022 (T+90)
- 10,000 shares46.6% of flowA股XSHESZSE:173000005304404320Canonical exit: 26 Apr 2022 (T+90)
- 1,265,400 shares40.4% of flowA股XSHESZSE:173000005246589630Canonical exit: 25 Apr 2022 (T+90)
- 514,000 shares15.8% of flowA股XSHESZSE:173000005069995870Canonical exit: 10 Feb 2022 (T+90)
- 25,000 shares0.7% of flowA股XSHESZSE:173000005041742370Canonical exit: 29 Nov 2021 (T+90)
- 662,000 shares16.5% of flowA股XSHESZSE:173000004701594430Canonical exit: 21 Nov 2021 (T+90)
14 of 14 declarations
About Jiangxi Fushine Pharmaceutical Co., Ltd.
富祥股份 is a company in the health and pharmaceutical sector, listed on the XSHE market. It specializes in the development and production of pharmaceutical products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
